# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001213900-21-040300
Filing Date
2021-08-04
Accepted
2021-08-04 16:01:30
Documents
49
Period of Report
2021-08-04
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | CURRENT REPORT | ea145181-8k_inmune.htm | 8-K | 16728
2 | PRESENTATION | ea145181ex99-1_inmune.htm | EX-99.1 | 51494
3 | GRAPHIC | ex99-1_001.jpg | GRAPHIC | 141102
4 | GRAPHIC | ex99-1_002.jpg | GRAPHIC | 165774
5 | GRAPHIC | ex99-1_003.jpg | GRAPHIC | 124753
6 | GRAPHIC | ex99-1_004.jpg | GRAPHIC | 91228
7 | GRAPHIC | ex99-1_005.jpg | GRAPHIC | 116413
8 | GRAPHIC | ex99-1_006.jpg | GRAPHIC | 120686
9 | GRAPHIC | ex99-1_007.jpg | GRAPHIC | 90076
10 | GRAPHIC | ex99-1_008.jpg | GRAPHIC | 128470
11 | GRAPHIC | ex99-1_009.jpg | GRAPHIC | 118894
12 | GRAPHIC | ex99-1_010.jpg | GRAPHIC | 98742
13 | GRAPHIC | ex99-1_011.jpg | GRAPHIC | 125969
14 | GRAPHIC | ex99-1_012.jpg | GRAPHIC | 81541
15 | GRAPHIC | ex99-1_013.jpg | GRAPHIC | 177009
16 | GRAPHIC | ex99-1_014.jpg | GRAPHIC | 118497
17 | GRAPHIC | ex99-1_015.jpg | GRAPHIC | 85877
18 | GRAPHIC | ex99-1_016.jpg | GRAPHIC | 179832
19 | GRAPHIC | ex99-1_017.jpg | GRAPHIC | 112410
20 | GRAPHIC | ex99-1_018.jpg | GRAPHIC | 152338
21 | GRAPHIC | ex99-1_019.jpg | GRAPHIC | 136329
22 | GRAPHIC | ex99-1_020.jpg | GRAPHIC | 96802
23 | GRAPHIC | ex99-1_021.jpg | GRAPHIC | 132521
24 | GRAPHIC | ex99-1_022.jpg | GRAPHIC | 115294
25 | GRAPHIC | ex99-1_023.jpg | GRAPHIC | 123895
26 | GRAPHIC | ex99-1_024.jpg | GRAPHIC | 113233
27 | GRAPHIC | ex99-1_025.jpg | GRAPHIC | 179903
28 | GRAPHIC | ex99-1_026.jpg | GRAPHIC | 133809
29 | GRAPHIC | ex99-1_027.jpg | GRAPHIC | 176970
30 | GRAPHIC | ex99-1_028.jpg | GRAPHIC | 111172
31 | GRAPHIC | ex99-1_029.jpg | GRAPHIC | 143607
32 | GRAPHIC | ex99-1_030.jpg | GRAPHIC | 171146
33 | GRAPHIC | ex99-1_031.jpg | GRAPHIC | 109186
34 | GRAPHIC | ex99-1_032.jpg | GRAPHIC | 113524
35 | GRAPHIC | ex99-1_033.jpg | GRAPHIC | 107606
36 | GRAPHIC | ex99-1_034.jpg | GRAPHIC | 147475
37 | GRAPHIC | ex99-1_035.jpg | GRAPHIC | 107635
38 | GRAPHIC | ex99-1_036.jpg | GRAPHIC | 132340
39 | GRAPHIC | ex99-1_037.jpg | GRAPHIC | 78485
40 | GRAPHIC | ex99-1_038.jpg | GRAPHIC | 124181
41 | GRAPHIC | ex99-1_039.jpg | GRAPHIC | 108707
42 | GRAPHIC | ex99-1_040.jpg | GRAPHIC | 174166
43 | GRAPHIC | ex99-1_041.jpg | GRAPHIC | 86032
44 | GRAPHIC | ex99-1_042.jpg | GRAPHIC | 121260
45 | GRAPHIC | ex99-1_043.jpg | GRAPHIC | 121670
46 | GRAPHIC | ex99-1_044.jpg | GRAPHIC | 120659
47 | GRAPHIC | ex99-1_045.jpg | GRAPHIC | 99123
48 | GRAPHIC | ex99-1_046.jpg | GRAPHIC | 81449
49 | GRAPHIC | ex99-1_047.jpg | GRAPHIC | 121719
| Complete submission text file | 0001213900-21-040300.txt |  | 8090053

Mailing Address 1200 PROSPECT STREET SUITE 525 LA JOLLA CA 92037
Business Address 1200 PROSPECT STREET SUITE 525 LA JOLLA CA 92037 8589643720
Inmune Bio, Inc. (Filer) CIK: 0001711754 (see all company filings)

EIN.: 475205835 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38793 | Film No.: 211143879
SIC: 2836 Biological Products, (No Diagnostic Substances)